Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

1 Aug 2011 07:00

RNS Number : 3794L
Creston PLC
01 August 2011
 



 

 

1 August 2011

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2011 to date.

 

Trading update

For the three months to 30 June 2011, the Group reported revenue growth of over 12 per cent. compared to the same period last year.

 

Like-for-like revenue growth for the first quarter was 2 per cent, compared to the same period in the prior year, which achieved a very strong 11 per cent. growth year on year.

 

The Insight division continued its recovery, delivering its strongest quarterly performance since the first quarter of the financial year 2011. The growth of existing and new clients such as Sainsbury's and Castrol, alongside being appointed to the BBC roster for the first time, adds momentum for the remainder of the year. The division is investing in its Insight Health proposition and is working closely with the Health division to maximise client opportunities.

 

The Communications division has begun the year strongly with a mixture of growth from existing clients and new business wins. As mentioned in the Preliminary Announcement on 21 June 2011, the Group launched Creston Unlimited, a brand consultancy, on 1 April and they have already won projects from existing group clients. NBC Hong Kong, a new start-up public relations offer, launches today and has already won its second pan-Asian client, having previously been appointed by HTC. Continuing the theme of organic start-ups, the Group has invested in a new local marketing health proposition, which combines EMO's local marketing expertise with that of the Health division in order to win new marketing mandates being created by the devolution of the NHS budgets. Lastly, the outcome of the previously highlighted re-tendering process by one of our top five client accounts remains outstanding, although fees are now confirmed until the end of September.

 

The Health division has been integral to the development of two new propositions within the Insight and Communications divisions, whilst in its own right winning some exciting new business, including an increasing number of global campaigns. Despite a slower start for the division, we are delighted with the strengthened global PR capability we are now able to offer clients with Cooney/Waters added to the Group.

 

Outlook

The Group entered the new year with positive momentum and the large new business opportunities currently being pitched for demonstrate the innovative offer that our companies have. There continues to be an increasing number of initiatives and client wins from working cohesively as one group and again this will add to the future growth.

 

Similar to previous years, the Group's financial performance in the current year will be weighted towards the second half and although management is cautious over the macro economic outlook, its current expectations for the full year remain unchanged.

 

 

Creston plc

020 7930 9757 www.creston.com

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

Elly Williams, M Communications

 

 

 

For further information, please contact:

(Like-for-like compares current year performance to prior year performance, excluding the results from any acquisitions.)

 

About Creston plc

 

Creston is a marketing services company focused on Insight and Communications. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across the Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

 

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAFXNAENFEFF
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.